$DNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENENTECH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENENTECH INC. Get notifications about new insider transactions in GENENTECH INC for free.
Page: < prev 1 ... 41 42 43 44 45 46 47 48 49 ... 52 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Buy | M | 24.25 | 6,900 | 167,325 | 9,939 | 3 K to 9.9 K (+227.05 %) |
| Mar 10 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Sell | S | 113.30 | 11,100 | 1,257,630 | 3,039 | 14.1 K to 3 K (-78.51 %) |
| Mar 10 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Buy | M | 24.25 | 11,100 | 269,175 | 14,139 | 3 K to 14.1 K (+365.25 %) |
| Mar 10 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Sell | S | 113.27 | 5,100 | 577,677 | 3,039 | 8.1 K to 3 K (-62.66 %) |
| Mar 10 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Buy | M | 24.25 | 5,100 | 123,675 | 8,139 | 3 K to 8.1 K (+167.82 %) |
| Mar 10 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Sell | S | 113.26 | 1,900 | 215,194 | 3,039 | 4.9 K to 3 K (-38.47 %) |
| Mar 10 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Buy | M | 24.25 | 1,900 | 46,075 | 4,939 | 3 K to 4.9 K (+62.52 %) |
| Mar 09 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Option Exercise | M | 45.90 | 1,400 | 64,260 | 31,250 | |
| Mar 09 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Option Exercise | M | 45.90 | 1,205 | 55,310 | 32,650 | |
| Mar 09 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Sell | S | 111.36 | 1,400 | 155,904 | 0 | 1.4 K to 0 (-100.00 %) |
| Mar 09 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Buy | M | 45.90 | 1,400 | 64,260 | 1,400 | 0 to 1.4 K |
| Mar 09 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Sell | S | 111.35 | 1,205 | 134,177 | 0 | 1.2 K to 0 (-100.00 %) |
| Mar 09 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Buy | M | 45.90 | 1,205 | 55,310 | 1,205 | 0 to 1.2 K |
| Mar 09 2004 | DNA | GENENTECH INC | ROCHE HOLDINGS INC | 10% Owner | Sell | C | 0.00 | 1,721,973 | 0 | 303,876,930 | 305.6 M to 303.9 M (-0.56 %) |
| Mar 09 2004 | DNA | GENENTECH INC | ROCHE HOLDINGS INC | 10% Owner | Sell | C | 0.00 | 263,919 | 0 | 305,598,903 | 305.9 M to 305.6 M (-0.09 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 7,000 | 169,750 | 1,219,652 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 2,000 | 48,500 | 1,226,652 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 21,500 | 521,375 | 1,228,652 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 2,000 | 48,500 | 1,250,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 7,000 | 169,750 | 1,252,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 5,000 | 121,250 | 1,259,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 15,000 | 363,750 | 1,264,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 5,000 | 121,250 | 1,279,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 1,000 | 24,250 | 1,284,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 15,000 | 363,750 | 1,285,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 4,500 | 109,125 | 1,300,152 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 10,000 | 242,500 | 1,304,652 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Option Exercise | M | 24.25 | 5,000 | 121,250 | 1,314,652 | |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.25 | 7,000 | 750,750 | 3,732 | 10.7 K to 3.7 K (-65.23 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 7,000 | 169,750 | 10,732 | 3.7 K to 10.7 K (+187.57 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.17 | 2,000 | 214,340 | 3,732 | 5.7 K to 3.7 K (-34.89 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 2,000 | 48,500 | 5,732 | 3.7 K to 5.7 K (+53.59 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.20 | 21,500 | 2,304,800 | 3,732 | 25.2 K to 3.7 K (-85.21 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 21,500 | 521,375 | 25,232 | 3.7 K to 25.2 K (+576.10 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.28 | 2,000 | 214,560 | 3,732 | 5.7 K to 3.7 K (-34.89 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 2,000 | 48,500 | 5,732 | 3.7 K to 5.7 K (+53.59 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.15 | 7,000 | 750,050 | 3,732 | 10.7 K to 3.7 K (-65.23 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 7,000 | 169,750 | 10,732 | 3.7 K to 10.7 K (+187.57 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 106.96 | 5,000 | 534,800 | 3,732 | 8.7 K to 3.7 K (-57.26 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 5,000 | 121,250 | 8,732 | 3.7 K to 8.7 K (+133.98 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.00 | 15,000 | 1,605,000 | 3,732 | 18.7 K to 3.7 K (-80.08 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 15,000 | 363,750 | 18,732 | 3.7 K to 18.7 K (+401.93 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.05 | 5,000 | 535,250 | 3,732 | 8.7 K to 3.7 K (-57.26 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 5,000 | 121,250 | 8,732 | 3.7 K to 8.7 K (+133.98 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 107.10 | 1,000 | 107,100 | 3,732 | 4.7 K to 3.7 K (-21.13 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 1,000 | 24,250 | 4,732 | 3.7 K to 4.7 K (+26.80 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 106.90 | 15,000 | 1,603,500 | 3,732 | 18.7 K to 3.7 K (-80.08 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 15,000 | 363,750 | 18,732 | 3.7 K to 18.7 K (+401.93 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 106.88 | 4,500 | 480,960 | 3,732 | 8.2 K to 3.7 K (-54.66 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 4,500 | 109,125 | 8,232 | 3.7 K to 8.2 K (+120.58 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 106.85 | 10,000 | 1,068,500 | 3,732 | 13.7 K to 3.7 K (-72.82 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 10,000 | 242,500 | 13,732 | 3.7 K to 13.7 K (+267.95 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Sell | S | 106.80 | 5,000 | 534,000 | 3,732 | 8.7 K to 3.7 K (-57.26 %) |
| Mar 05 2004 | DNA | GENENTECH INC | LEVINSON ARTHUR D | CHAIRMAN, PRESIDENT ... | Buy | M | 24.25 | 5,000 | 121,250 | 8,732 | 3.7 K to 8.7 K (+133.98 %) |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Option Exercise | M | 24.25 | 2,000 | 48,500 | 84,872 | |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Option Exercise | M | 24.25 | 6,000 | 145,500 | 86,872 | |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Option Exercise | M | 24.25 | 67,000 | 1,624,750 | 92,872 | |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Sell | S | 107.20 | 2,000 | 214,400 | 3,039 | 5 K to 3 K (-39.69 %) |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Buy | M | 24.25 | 2,000 | 48,500 | 5,039 | 3 K to 5 K (+65.81 %) |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Sell | S | 107.15 | 6,000 | 642,900 | 3,039 | 9 K to 3 K (-66.38 %) |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Buy | M | 24.25 | 6,000 | 145,500 | 9,039 | 3 K to 9 K (+197.43 %) |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Sell | S | 107.05 | 67,000 | 7,172,350 | 3,039 | 70 K to 3 K (-95.66 %) |
| Mar 05 2004 | DNA | GENENTECH INC | JUELSGAARD STEPHEN G | EVP, GEN COUNSEL & ... | Buy | M | 24.25 | 67,000 | 1,624,750 | 70,039 | 3 K to 70 K (+2,204.67 %) |
| Mar 05 2004 | DNA | GENENTECH INC | ROCHE HOLDINGS INC | 10% Owner | Sell | C | 0.00 | 302,855 | 0 | 305,862,822 | 306.2 M to 305.9 M (-0.10 %) |
| Mar 05 2004 | DNA | GENENTECH INC | ROCHE HOLDINGS INC | 10% Owner | Sell | C | 0.00 | 37,120 | 0 | 306,165,677 | 306.2 M to 306.2 M (-0.01 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Option Exercise | M | 24.25 | 15,000 | 363,750 | 81,640 | |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Option Exercise | M | 24.25 | 4,000 | 97,000 | 96,640 | |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Option Exercise | M | 24.25 | 4,000 | 97,000 | 100,640 | |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Option Exercise | M | 24.25 | 2,000 | 48,500 | 104,640 | |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Sell | S | 105.66 | 15,000 | 1,584,900 | 3,289 | 18.3 K to 3.3 K (-82.02 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Buy | M | 24.25 | 15,000 | 363,750 | 18,289 | 3.3 K to 18.3 K (+456.07 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Sell | S | 105.72 | 4,000 | 422,880 | 3,289 | 7.3 K to 3.3 K (-54.88 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Buy | M | 24.25 | 4,000 | 97,000 | 7,289 | 3.3 K to 7.3 K (+121.62 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Sell | S | 105.75 | 4,000 | 423,000 | 3,289 | 7.3 K to 3.3 K (-54.88 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Buy | M | 24.25 | 4,000 | 97,000 | 7,289 | 3.3 K to 7.3 K (+121.62 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Sell | S | 105.85 | 2,000 | 211,700 | 3,289 | 5.3 K to 3.3 K (-37.81 %) |
| Mar 04 2004 | DNA | GENENTECH INC | EBERSMAN DAVID A | SENIOR VICE PRESIDE ... | Buy | M | 24.25 | 2,000 | 48,500 | 5,289 | 3.3 K to 5.3 K (+60.81 %) |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Option Exercise | M | 45.90 | 2,604 | 119,524 | 33,855 | |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Option Exercise | M | 41.80 | 1,354 | 56,597 | 25,730 | |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Option Exercise | M | 41.80 | 454 | 18,977 | 27,084 | |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Option Exercise | M | 41.80 | 900 | 37,620 | 27,538 | |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Option Exercise | M | 28.55 | 3,646 | 104,093 | 113,021 | |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Sell | S | 107.15 | 3,646 | 390,669 | 0 | 3.6 K to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Buy | M | 28.55 | 3,646 | 104,093 | 3,646 | 0 to 3.6 K |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Sell | S | 107.15 | 1,354 | 145,081 | 0 | 1.4 K to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Buy | M | 41.80 | 1,354 | 56,597 | 1,354 | 0 to 1.4 K |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Sell | S | 109.49 | 454 | 49,708 | 0 | 454 to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Buy | M | 41.80 | 454 | 18,977 | 454 | 0 to 454 |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Sell | S | 109.51 | 900 | 98,559 | 0 | 900 to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Buy | M | 41.80 | 900 | 37,620 | 900 | 0 to 900 |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Sell | S | 107.15 | 2,604 | 279,019 | 0 | 2.6 K to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | SCHELLER RICHARD H | EVP, RESEARCH | Buy | M | 45.90 | 2,604 | 119,524 | 2,604 | 0 to 2.6 K |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Option Exercise | M | 42.94 | 3,600 | 154,575 | 7,500 | |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Option Exercise | M | 42.94 | 1,800 | 77,288 | 11,100 | |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Option Exercise | M | 42.94 | 2,100 | 90,169 | 12,900 | |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Sell | S | 108.68 | 3,600 | 391,248 | 0 | 3.6 K to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Buy | M | 42.94 | 3,600 | 154,575 | 3,600 | 0 to 3.6 K |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Sell | S | 108.68 | 1,800 | 195,624 | 0 | 1.8 K to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Buy | M | 42.94 | 1,800 | 77,288 | 1,800 | 0 to 1.8 K |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Sell | S | 108.75 | 2,100 | 228,375 | 0 | 2.1 K to 0 (-100.00 %) |
| Mar 02 2004 | DNA | GENENTECH INC | RICHMOND MARK SIR | Director | Buy | M | 42.94 | 2,100 | 90,169 | 2,100 | 0 to 2.1 K |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 5,000 | 121,250 | 223,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 4,000 | 97,000 | 228,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 15,000 | 363,750 | 232,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 10,000 | 242,500 | 247,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 6,000 | 145,500 | 257,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 23,000 | 557,750 | 263,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 8,000 | 194,000 | 286,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 11,600 | 281,300 | 294,104 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 2,000 | 48,500 | 305,704 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 4,500 | 109,125 | 307,704 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 5,500 | 133,375 | 312,204 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 2,100 | 50,925 | 317,704 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Option Exercise | M | 24.25 | 3,300 | 80,025 | 319,804 | |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.70 | 5,000 | 548,500 | 1,880 | 6.9 K to 1.9 K (-72.67 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 5,000 | 121,250 | 6,880 | 1.9 K to 6.9 K (+265.96 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.76 | 4,000 | 439,040 | 1,880 | 5.9 K to 1.9 K (-68.03 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 4,000 | 97,000 | 5,880 | 1.9 K to 5.9 K (+212.77 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.50 | 15,000 | 1,642,500 | 1,880 | 16.9 K to 1.9 K (-88.86 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 15,000 | 363,750 | 16,880 | 1.9 K to 16.9 K (+797.87 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.30 | 10,000 | 1,093,000 | 1,880 | 11.9 K to 1.9 K (-84.18 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 10,000 | 242,500 | 11,880 | 1.9 K to 11.9 K (+531.91 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.25 | 6,000 | 655,500 | 1,880 | 7.9 K to 1.9 K (-76.14 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 6,000 | 145,500 | 7,880 | 1.9 K to 7.9 K (+319.15 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.20 | 23,000 | 2,511,600 | 1,880 | 24.9 K to 1.9 K (-92.44 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 23,000 | 557,750 | 24,880 | 1.9 K to 24.9 K (+1,223.40 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.15 | 8,000 | 873,200 | 1,880 | 9.9 K to 1.9 K (-80.97 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 8,000 | 194,000 | 9,880 | 1.9 K to 9.9 K (+425.53 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.10 | 11,600 | 1,265,560 | 1,880 | 13.5 K to 1.9 K (-86.05 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 11,600 | 281,300 | 13,480 | 1.9 K to 13.5 K (+617.02 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.09 | 2,000 | 218,180 | 1,880 | 3.9 K to 1.9 K (-51.55 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 2,000 | 48,500 | 3,880 | 1.9 K to 3.9 K (+106.38 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.07 | 4,500 | 490,815 | 1,880 | 6.4 K to 1.9 K (-70.53 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 4,500 | 109,125 | 6,380 | 1.9 K to 6.4 K (+239.36 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.05 | 5,500 | 599,775 | 1,880 | 7.4 K to 1.9 K (-74.53 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 5,500 | 133,375 | 7,380 | 1.9 K to 7.4 K (+292.55 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.02 | 2,100 | 228,942 | 1,880 | 4 K to 1.9 K (-52.76 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 2,100 | 50,925 | 3,980 | 1.9 K to 4 K (+111.70 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Sell | S | 109.00 | 3,300 | 359,700 | 1,880 | 5.2 K to 1.9 K (-63.71 %) |
| Mar 02 2004 | DNA | GENENTECH INC | DESMOND HELLMANN SUSAN D | EVP & CHIEF MEDICAL ... | Buy | M | 24.25 | 3,300 | 80,025 | 5,180 | 1.9 K to 5.2 K (+175.53 %) |
| Mar 02 2004 | DNA | GENENTECH INC | ROCHE HOLDINGS INC | 10% Owner | Sell | C | 0.00 | 389,392 | 0 | 306,202,797 | 306.6 M to 306.2 M (-0.13 %) |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Option Exercise | M | 81.97 | 37,500 | 3,073,875 | 7,500 | |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Option Exercise | M | 41.80 | 5,058 | 211,424 | 25,292 | |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Option Exercise | M | 28.55 | 6,250 | 178,438 | 50,000 | |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Sell | S | 100.00 | 6,250 | 625,000 | 206 | 6.5 K to 206 (-96.81 %) |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Buy | M | 28.55 | 6,250 | 178,438 | 6,456 | 206 to 6.5 K (+3,033.98 %) |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Sell | S | 100.00 | 5,058 | 505,800 | 206 | 5.3 K to 206 (-96.09 %) |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Buy | M | 41.80 | 5,058 | 211,424 | 5,264 | 206 to 5.3 K (+2,455.34 %) |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Sell | S | 100.00 | 37,500 | 3,750,000 | 206 | 37.7 K to 206 (-99.45 %) |
| Mar 01 2004 | DNA | GENENTECH INC | GARNICK ROBERT L | SENIOR VICE PRESIDE ... | Buy | M | 81.97 | 37,500 | 3,073,875 | 37,706 | 206 to 37.7 K (+18,203.88 %) |